Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 320

1.
2.

[Theophylline in the treatment of chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study].

Zhou YM, Wang XP, Zeng XY, Qiu R, Xie JF, Liu SM, Zheng JP, Zhong NS, Ran PX.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Sep;29(9):577-82. Chinese.

PMID:
17129461
3.

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105.

4.

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.

Di Lorenzo G, Morici G, Drago A, Pellitteri ME, Mansueto P, Melluso M, Norrito F, Squassante L, Fasolo A.

Clin Ther. 1998 Nov-Dec;20(6):1130-48.

PMID:
9916607
5.

[Clinical and functional benefits of adding theophylline to a standard treatment with short acting bronchodilators in patients with COPD].

Dreyse J, Silva F, Díaz O, Borzone G, Lisboa C.

Rev Med Chil. 2005 Oct;133(10):1211-9. Epub 2005 Dec 5. Spanish.

6.

A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.

Rutten-van Mölken MP, van Nooten FE, Lindemann M, Caeser M, Calverley PM.

Pharmacoeconomics. 2007;25(8):695-711.

PMID:
17640111
7.

Bu-Fei Yi-Shen granule combined with acupoint sticking therapy in patients with stable chronic obstructive pulmonary disease: a randomized, double-blind, double-dummy, active-controlled, 4-center study.

Li JS, Li SY, Yu XQ, Xie Y, Wang MH, Li ZG, Zhang NZ, Shao SJ, Zhang YJ, Zhu L, Guo LX, Bai YP, Wang YF.

J Ethnopharmacol. 2012 Jun 1;141(2):584-91. doi: 10.1016/j.jep.2011.08.060. Epub 2011 Sep 5.

PMID:
21911051
8.

Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.

Minami S, Kawayama T, Ichiki M, Nishiyama M, Sueyasu Y, Gohara R, Kinoshita M, Koga H, Iwanaga T, Aizawa H.

Intern Med. 2008;47(6):503-9. Epub 2008 Mar 17.

9.
10.

Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.

Murali PM, Rajasekaran S, Paramesh P, Krishnarajasekar OR, Vasudevan S, Nalini K, Lakshmisubramanian S, Deivanayagam CN.

Respir Med. 2006 Jan;100(1):39-45.

11.

The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation.

Laursen LC, Lindqvist A, Hepburn T, Lloyd J, Perrett J, Sanders N, Rocchiccioli K.

Respir Med. 2003 Jan;97 Suppl A:S23-33.

PMID:
12564608
12.

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S.

Ann Intern Med. 2005 Sep 6;143(5):317-26.

PMID:
16144890
13.

The efficacy and safety of cilomilast in COPD.

Rennard S, Knobil K, Rabe KF, Morris A, Schachter N, Locantore N, Canonica WG, Zhu Y, Barnhart F.

Drugs. 2008;68 Suppl 2:3-57. doi: 10.2165/0003495-200868002-00002. Review.

PMID:
19105585
14.
15.

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.

Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.

Respir Med. 2008 Aug;102(8):1099-108. doi: 10.1016/j.rmed.2008.04.019. Epub 2008 Jul 9.

16.
17.

Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Ram FS, Jardin JR, Atallah A, Castro AA, Mazzini R, Goldstein R, Lacasse Y, Cendon S.

Respir Med. 2005 Feb;99(2):135-44. Review.

PMID:
15715180
18.

Effect of add-on therapy of tiotropium in COPD treated with theophylline.

Kawayama T, Hoshino T, Ichiki M, Tsuda T, Kinoshita M, Takata S, Koga T, Iwanaga T, Aizawa H; Kurume COPD Study Group.

Int J Chron Obstruct Pulmon Dis. 2008;3(1):137-47.

19.
20.

Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.

Devereux G, Cotton S, Barnes P, Briggs A, Burns G, Chaudhuri R, Chrystyn H, Davies L, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, McCormack K, McPherson G, Morice A, Norrie J, Sullivan A, Wilson A, Price D.

Trials. 2015 Jun 10;16:267. doi: 10.1186/s13063-015-0782-2.

Supplemental Content

Support Center